Clindamycin Phosphate Topical Solution recalled due to defective container leakage
Contract Pharmaceuticals Limited Canada is recalling Clindamycin Phosphate Topical Solution 1% due to defective containers with slow leakage. Lot 119874 (expires 06/30/2025) distributed nationwide in the U.S. and Puerto Rico is affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard is a container defect affecting product integrity, which represents a theoretical risk rather than documented harm.
Plain-English summary
Contract Pharmaceuticals Limited Canada is recalling Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottles due to defective containers. The containers are out of specification for weight as a result of slow leakage discovered at the 12-month stability testing timepoint.
The affected product is Lot #119874 with an expiration date of 06/30/2025, manufactured for Glasshouse Pharmaceuticals Limited Canada. The recall covers 11,750 bottles distributed nationwide in the United States and Puerto Rico.
Consumers who have this product should contact their healthcare provider or pharmacist for guidance. Do not use the product without consulting a medical professional.
The recalled product
- Product
- Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60
- Manufacturer
- Contract Pharmaceuticals Limited Canada
- Category
- Drug — Topical Solution
- Hazard
- Affected units
- 11,750
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 119874
- Exp 06/30/2025
Distribution
Part of a larger recall action
This product is one of 2 recalled by Contract Pharmaceuticals Limited Canada under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Contract Pharmaceuticals Limited Canada
See all →- ModerateClindamycin Phosphate Topical Solution recalled for defective container leakage
FDA (Drugs) · 2024-03-13
- LowClindamycin Phosphate Topical Solution Recalled for Defective Container
FDA (Drugs) · 2023-09-06
Same hazard · container defect
See all →- HighOphthalmic solution recalled for defective container with lodged spike
FDA (Drugs) · 2024-08-21
- ModeratePEG-3350 Oral Solution Recalled for Defective Non-Sealed Pouches
FDA (Drugs) · 2024-08-14
- ModerateAsmanex (Mometasone Furoate) Recalled Due to Defective Container
FDA (Drugs) · 2024-06-19
- HighTimolol Maleate ophthalmic solution recalled for defective container cap nozzle
FDA (Drugs) · 2024-05-15
- HighPotassium Chloride Injection Recalled Due to Pinhole Container Defects
FDA (Drugs) · 2024-03-20